Premium
Pliant Therapeutics Inc (PLRX)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.16 | -9.69696969697 | 1.65 | 1.72 | 1.485 | 2390010 | 1.60850938 | CS |
| 4 | -1.57 | -51.3071895425 | 3.06 | 3.46 | 1.26 | 3704293 | 1.77745312 | CS |
| 12 | -11.38 | -88.4226884227 | 12.87 | 13.71 | 1.26 | 2728052 | 3.25845929 | CS |
| 26 | -9.85 | -86.860670194 | 11.34 | 16.1 | 1.26 | 1494163 | 5.14045636 | CS |
| 52 | -13.24 | -89.8845892736 | 14.73 | 16.52 | 1.26 | 970612 | 6.95394098 | CS |
| 156 | -6.08 | -80.3170409511 | 7.57 | 36.64 | 1.26 | 826707 | 15.46732634 | CS |
| 260 | -21.01 | -93.3777777778 | 22.5 | 43.92 | 1.26 | 563649 | 16.22093192 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
